70 Spam-Free Article(s) Found
Sort:
Like
Filter:
All
Article Searches
Fortuna Silver (FSM) Q1 Gold Equivalent Production Rises 20% Y/Y https://www.zacks.com/stock/news/2252804/fortuna-silver-fsm-q1-gold-equivalent-production-rises-20-y-y?cid=CS-ZC-FT-analyst_blog|company_news_-_corporate_actions-2252804 Apr 09, 2024 - Fortuna Silver (FSM) reports a 20% improvement in gold equivalent ounces produced in the first quarter of 2024, bolstered by higher gold output.
Air Liquide (AIQUY) Expands Biomethane Production in U.S. https://www.zacks.com/stock/news/2254790/air-liquide-aiquy-expands-biomethane-production-in-u-s?cid=CS-ZC-FT-analyst_blog|company_news_-_corporate_actions-2254790 Apr 12, 2024 - Air Liquide (AIQUY) expands U.S. biomethane production with two new units, promoting a circular economy and supporting decarbonization efforts.
Eldorado Gold (EGO) Updates on Q1 Tax Impacts in Turkiye https://www.zacks.com/stock/news/2254775/eldorado-gold-ego-updates-on-q1-tax-impacts-in-turkiye?cid=CS-ZC-FT-analyst_blog|company_news_-_corporate_actions-2254775 Apr 12, 2024 - Eldorado Gold (EGO) updates on the tax impacts in Turkiye related to the weakening of the Turkish Lira in the first quarter of 2024.
Will Materials ETFs Gain Further as Q1 Earnings Unfold? https://www.zacks.com/stock/news/2257915/will-materials-etfs-gain-further-as-q1-earnings-unfold?cid=CS-ZC-FT-etf_news_and_commentary-2257915 Apr 18, 2024 - Going into the Q1 earnings season, earnings releases from the sector giants will determine the movement of these funds.
3 Dividend Aristocrats to Take the Edge off Market Volatility https://www.zacks.com/stock/news/2259379/3-dividend-aristocrats-to-take-the-edge-off-market-volatility?cid=CS-ZC-FT-analyst_blog|investment_ideas-2259379 Apr 22, 2024 - With markets remaining topsy-turvy, it's prudent for astute investors to pick dividend aristocrats like Atmos Energy (ATO), Ecolab (ECL) and SherwinWilliams (SHW) for steady income.
Reasons Why You Should Retain HealthEquity (HQY) Stock for Now https://www.zacks.com/stock/news/2260548/reasons-why-you-should-retain-healthequity-hqy-stock-for-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2260548 Apr 23, 2024 - HealthEquity's (HQY) sustained strength in HSAs raises optimism about the stock.
Penumbra's (PEN) New Launch to Enhance Blood Clot Removal https://www.zacks.com/stock/news/2261445/penumbra-s-pen-new-launch-to-enhance-blood-clot-removal?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2261445 Apr 24, 2024 - Penumbra's (PEN) latest offering is likely to enable physicians to restore blood flow more quickly and further minimize blood loss.
Here's Why You Should Hold Lantheus (LNTH) in Your Portfolio Now https://www.zacks.com/stock/news/2265409/here-s-why-you-should-hold-lantheus-lnth-in-your-portfolio-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2265409 Apr 30, 2024 - Lantheus' (LNTH) focus on pipeline development raises optimism about the stock.
Quest Diagnostics (DGX) Grows in Digital Pathology With New Deal https://www.zacks.com/stock/news/2269766/quest-diagnostics-dgx-grows-in-digital-pathology-with-new-deal?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2269766 May 07, 2024 - Quest Diagnostics' (DGX) pathology laboratories nationwide are set to get a boost with PathAI's AISight digital pathology image management system.
Are You Looking for a Top Momentum Pick? Why Ecolab (ECL) is a Great Choice https://www.zacks.com/stock/news/2269824/are-you-looking-for-a-top-momentum-pick-why-ecolab-ecl-is-a-great-choice?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_10-2269824 May 07, 2024 - Does Ecolab (ECL) have what it takes to be a top stock pick for momentum investors? Let's find out.

Pages: 1234567

<<<Page 7